Scott M. Plesha

CEO

Chief Executive Officer

US·SEC (Form 4)

Pelthos Therapeutics Inc.Biodelivery Sciences International Inc

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 01 Apr 2026 for Pelthos Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Scott M. Plesha: trading record in brief

Scott M. Plesha is a declared insider at 2 companies (chief executive); the most frequent names are Biodelivery Sciences International Inc and Pelthos Therapeutics Inc. We count 3 filings; the first trade dates from 27 January 2022 and the latest from 2 July 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 1 April 2026, reports a share grant in Pelthos Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.